Mamoor, S. (2025). Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3. Zenodo.
Style de citation Chicago (17e éd.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor Positive Triple Negative Breast Cancer (AR+ TNBC): GRK3. Zenodo, 2025.
Style de citation MLA (9e éd.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor Positive Triple Negative Breast Cancer (AR+ TNBC): GRK3. Zenodo, 2025.
Attention : ces citations peuvent ne pas être correctes à 100%.